Cancer Community(암 커뮤니티)란 무엇입니까?
Cancer Community 암 커뮤니티 - Cultivating a women-focused heart disease online community might replicate some of the #BreastCancer community’s successes. [1] To enable these molecular tumor characterizations to effectively and safely inform cancer care, the cancer community is working to develop and validate multiparameter omics tests and imaging tests as well as software and computational methods for interpretation of the resulting datasets. [2] As the steward of the Canadian Strategy for Cancer Control (the Strategy), the Partnership works with Canada’s cancer community to take action to ensure fewer people get cancer, more people survive cancer and those living with the disease have a better quality of life. [3] However, Armstrong’s positive social impact of raising awareness, hundreds of millions of dollars, and support for the cancer community are undeniably noteworthy. [4] Five breast cancer patients were recruited from an online survey, cancer community and traditional treatment clinic. [5] These ClinGen efforts rely on broad data sharing and detailed phenotypic and molecular information from published case studies to provide expert-curated variant interpretation to the cancer community. [6] The Food and Drug Administration is undertaking a pilot project to develop a process and criteria for updating prescribing information for longstanding oncology drugs, based on the breadth of knowledge the cancer community has accumulated with the use of these drugs over time. [7] The PAAC and Bayer teams have identified important learnings from the first phase of the program, emphasizing earlier engagement of patient advisors, launching the enhanced training platform, and recruiting additional PAAC members to expand the initiative’s reach across the cancer community. [8] BackgroundThe roles played by cholesterol in cancer development and progression represent a popular field in the cancer community. [9] In addition, the cancer community is also influenced by a vast amount of pathological and clinical immunological research observations that host immune system plays a central role in preventing the development and spread of cancer. [10]여성 중심의 심장 질환 온라인 커뮤니티를 육성하는 것은 #BreastCancer 커뮤니티의 성공을 일부 복제할 수 있습니다. [1] 이러한 분자 종양 특성 분석이 암 치료에 효과적이고 안전하게 정보를 제공할 수 있도록 암 커뮤니티는 결과 데이터 세트의 해석을 위한 소프트웨어 및 계산 방법은 물론 다중 매개변수 omics 테스트 및 이미징 테스트를 개발하고 검증하기 위해 노력하고 있습니다. [2] 암 통제를 위한 캐나다 전략(전략)의 청지기로서, 파트너십은 더 적은 사람들이 암에 걸리고, 더 많은 사람들이 암에서 생존하고, 질병을 앓고 있는 사람들이 더 나은 삶의 질을 누릴 수 있도록 조치를 취하기 위해 캐나다의 암 커뮤니티와 협력합니다. [3] 그러나 암스트롱의 인식 제고, 수억 달러, 암 커뮤니티 지원에 대한 긍정적인 사회적 영향은 부인할 수 없습니다. [4] 5명의 유방암 환자가 온라인 설문조사, 암 커뮤니티 및 전통 치료 클리닉에서 모집되었습니다. [5] 이러한 ClinGen의 노력은 암 커뮤니티에 전문가가 선별한 변이체 해석을 제공하기 위해 공개된 사례 연구의 광범위한 데이터 공유와 상세한 표현형 및 분자 정보에 의존합니다. [6] 미국 식품의약국(FDA)은 암 커뮤니티가 시간이 지남에 따라 이러한 약물을 사용하여 축적한 지식의 폭을 기반으로 오랜 기간 지속되는 종양 약물에 대한 처방 정보를 업데이트하기 위한 프로세스 및 기준을 개발하기 위한 파일럿 프로젝트를 수행하고 있습니다. [7] PAAC와 바이엘 팀은 프로그램의 첫 번째 단계에서 중요한 교훈을 확인했으며, 환자 고문의 조기 참여를 강조하고 향상된 교육 플랫폼을 출시하고 추가 PAAC 회원을 모집하여 암 커뮤니티 전반에 걸쳐 이니셔티브의 범위를 확장했습니다. [8] 배경 암 발병 및 진행에서 콜레스테롤이 하는 역할은 암 커뮤니티에서 인기 있는 분야입니다. [9] 또한 암 커뮤니티는 숙주 면역 체계가 암의 발병 및 확산을 예방하는 데 중심적인 역할을 한다는 방대한 양의 병리학적 및 임상 면역학적 연구 관찰에 의해 영향을 받습니다. [10]
lung cancer patient
Introduction: While access to health care is free in Australia, access to lung cancer treatments is not always affordable or timely, especially for a rare cancer patient like the author Diagnosed with ROS1+ NSCLC, the author had to crowdfund to pay for her first targeted therapy the price of which exceeded what most Australians could afford Acutely aware that her participation in a subsequent clinical trial is uncommon for someone with a similar minority background, the author seeks to explore the concept of patient experience in the context of diversity and inequity Patient experience is multidimensional and integrated The quality and safety of services provided, the costs incurred, and the outcomes achieved are all important facets of the patient experience [1] The ultimate goals of advocates are to achieve optimal patient experience by ensuring that patients’ needs are heard, and problems are resolved To do this effectively, advocates must understand the unmet needs of the patients they seek to represent However, lung cancer patient experience is not homogenous and is impacted by social determinants In Australia, lung cancer outcomes differ across socioeconomic status (SES), indigenous status and remoteness For example: (a) the incidence rates of lung cancer in 2010-14 were 27% higher in remote and very remote areas combined, compared to major Australian cities;(b) the mortality rate was highest in the lowest SES areas (SES1, 38 5 per 100,000 persons), compared to the highest SES areas (SES5, 20 1 per 100,000 persons);and (c) the 5-year survival rate for lung cancer in 2010-2014 was 8 5% for Indigenous Australians compared to 14 2% for non-Indigenous Australians [2] Health inequities exist both within and among countries [3], so the lung cancer patient experience would no doubt also differ within and between countries The aim of this presentation is to draw insights from the author’s lung cancer patient experience as well as patient anecdotes from other countries and continents Method: Three separate interviews were conducted through a cloud-based video conference service The interviewees were asked to share stories of lung cancer patient experience in their country, observations on key areas of improvement, and comments on how the global lung cancer community can support them Results: The interviewees comprised of two female lung cancer patients from the Netherlands and New Zealand, and a male lung cancer advocate from Nigeria Interview 1: Experience from The Netherlands: The insights of the patient advocate from the Netherlands were mostly very positive She described her experience of free access to healthcare, timely and free access to treatment, optimal level of nursing care, and integrated psychosocial services While there remains is a need to address stigma systematically and collaboratively, the interviewee observes that lung cancer care in the Netherlands may be held as a model for healthcare Interview 2: Experience from New Zealand: The anecdotes shared by the patient advocate from New Zealand somewhat differ While access to healthcare is free, most lung cancer patients are treated by general oncologists The patient advocate’s key area of concern is the limited access to biomarker testing, treatment options and clinicals trials She calls on the global lung cancer community to raise awareness about the lack of treatment options in New Zealand Interview 3: Experience from Nigeria: The third interview was with a former caregiver and advocate from Nigeria provided anecdotes and observations that were drastically different from the others Tragically, because healthcare costs are not subsidized and can be prohibitive, many people do not get diagnosed at all If diagnosed, a lung cancer patient would attend a general cancer clinic to see a general oncologist Treatment options are very limited as there is currently no access to any lung cancer biomarker testing, targeted therapy or immunotherapy There are currently no lung cancer clinical trials in Nigeria The interviewee descr bed feelings of sadness and despair when watching presentations on global lung cancer research and medical advancements He believes that the first step to tackle the dire position of lung cancer patients in Nigeria and Africa is to understand the current standard of lung cancer care in these respective areas He calls on the global community to provide support in that regard Conclusion: Lung cancer patient experience is not only multidimensional but also diverse The key insights drawn from the interviews are that, to ensure a comprehensive lung cancer patient experience, it is crucial that: (a) lung cancer advocates are aware and mindful of social determinants as well as issues that can significantly impact on patient outcomes, including inequity, accessibility, resourcing and poverty;(b) lung cancer researchers, clinicians and policy makers actively address disparities by engaging with a wide variety of patients and caregivers in their work;and (c) the lung cancer global community is sensitive to the impact of accelerating medical advancements on the widening gap of global health inequities, and ensure that all communication is appropriately respectful The reduction of inequities is a moral obligation [4] It may be difficult to comprehend in the year of the dawn of COVID-19, but it is time for us to advance beyond just tackling diseases It is our collective ethical responsibility to consider the whole patient experience in all aspects of lung cancer care, and to do so through the lenses of health inequities As the World Health Organisation states “[r]educing health inequities is… an ethical imperative Social injustice is killing people on a grand scale ” [5] Acknowledgements: My gratitude to Caleb Egwuenu, Lily Huang and Merel Hennink for generously sharing their time and experience which significantly contributed to this presentation References: [1] Wolf, Jason A The future of patient experience: Five thoughts on where we must go from here Patient Experience Journal 2019;6(3):1 [2] Cancer Australia National Cancer Control Indicators 2019 [3] United Nations Sustainable development goals 10: Reduced inequalities [4] World Health Organisation Closing the gap in a generation: Health equity through action on the social determinants of Health WHO Press 2008 [5] Ibid, at p 40 Keywords: Health inequities, Integrated patient experience, Access to care and treatment. [1]Breast Cancer Community
The purpose of this study was to determine whether there is a relationship between family support and compliance with breast cancer patients in the Breast Cancer Community in Gresik. [1] CONCLUSION MBC links participants' lives to individuals from their preexisting relationships, new friendships, and the breast cancer community in irrevocable ways. [2] Conclusions: Breast pain is a significant problem in our breast cancer community. [3] Methods: The method of this study used descriptive analysis, the study was conducted in the breast cancer community in Surabaya, East Java. [4] Arguably, it is particularly more crucial in the world of breast cancer, as we as a breast cancer community are tirelessly assembling to advocate for our patients on a variety of levels, whether it is including but not limited to, breast cancer screening, diagnosis, and treatment, access-to-care, education, or research funding. [5] The current study investigated the sentiment dynamics in patients' narratives in a Breast Cancer community group (Breastcancer. [6] Cancer-specific hashtags modeled on a breast cancer community, #bcsm, led to the development of a structured set of hashtags called the cancer tag ontology. [7]nan [1] nan [2] nan [3] nan [4] nan [5] nan [6] 유방암 커뮤니티 #bcsm을 모델로 한 암 관련 해시태그는 암 태그 온톨로지라는 구조화된 해시태그 세트의 개발로 이어졌습니다. [7]
Lung Cancer Community
In conclusion ASCO 2021 provided the lung cancer community with inspiring new data especial in early stages and challenges the community with integration of these data into our daily clinical routine. [1] The overwhelming impact of COVID-19 on lung cancer community may result in rise of the incidence and mortality of lung cancer. [2] This rapid global mobilization of the lung cancer community through the CLCC and the resulting Serological Center of Excellence is positioned to answer fundamental questions regarding the susceptibility of patients with lung cancer to SARS-CoV-2 infection and severe COVID-19 disease and provide information to allow assessment of the value of vaccination and the utility of specifically designed vaccine programs for this high-risk patient population. [3] Introduction: While access to health care is free in Australia, access to lung cancer treatments is not always affordable or timely, especially for a rare cancer patient like the author Diagnosed with ROS1+ NSCLC, the author had to crowdfund to pay for her first targeted therapy the price of which exceeded what most Australians could afford Acutely aware that her participation in a subsequent clinical trial is uncommon for someone with a similar minority background, the author seeks to explore the concept of patient experience in the context of diversity and inequity Patient experience is multidimensional and integrated The quality and safety of services provided, the costs incurred, and the outcomes achieved are all important facets of the patient experience [1] The ultimate goals of advocates are to achieve optimal patient experience by ensuring that patients’ needs are heard, and problems are resolved To do this effectively, advocates must understand the unmet needs of the patients they seek to represent However, lung cancer patient experience is not homogenous and is impacted by social determinants In Australia, lung cancer outcomes differ across socioeconomic status (SES), indigenous status and remoteness For example: (a) the incidence rates of lung cancer in 2010-14 were 27% higher in remote and very remote areas combined, compared to major Australian cities;(b) the mortality rate was highest in the lowest SES areas (SES1, 38 5 per 100,000 persons), compared to the highest SES areas (SES5, 20 1 per 100,000 persons);and (c) the 5-year survival rate for lung cancer in 2010-2014 was 8 5% for Indigenous Australians compared to 14 2% for non-Indigenous Australians [2] Health inequities exist both within and among countries [3], so the lung cancer patient experience would no doubt also differ within and between countries The aim of this presentation is to draw insights from the author’s lung cancer patient experience as well as patient anecdotes from other countries and continents Method: Three separate interviews were conducted through a cloud-based video conference service The interviewees were asked to share stories of lung cancer patient experience in their country, observations on key areas of improvement, and comments on how the global lung cancer community can support them Results: The interviewees comprised of two female lung cancer patients from the Netherlands and New Zealand, and a male lung cancer advocate from Nigeria Interview 1: Experience from The Netherlands: The insights of the patient advocate from the Netherlands were mostly very positive She described her experience of free access to healthcare, timely and free access to treatment, optimal level of nursing care, and integrated psychosocial services While there remains is a need to address stigma systematically and collaboratively, the interviewee observes that lung cancer care in the Netherlands may be held as a model for healthcare Interview 2: Experience from New Zealand: The anecdotes shared by the patient advocate from New Zealand somewhat differ While access to healthcare is free, most lung cancer patients are treated by general oncologists The patient advocate’s key area of concern is the limited access to biomarker testing, treatment options and clinicals trials She calls on the global lung cancer community to raise awareness about the lack of treatment options in New Zealand Interview 3: Experience from Nigeria: The third interview was with a former caregiver and advocate from Nigeria provided anecdotes and observations that were drastically different from the others Tragically, because healthcare costs are not subsidized and can be prohibitive, many people do not get diagnosed at all If diagnosed, a lung cancer patient would attend a general cancer clinic to see a general oncologist Treatment options are very limited as there is currently no access to any lung cancer biomarker testing, targeted therapy or immunotherapy There are currently no lung cancer clinical trials in Nigeria The interviewee descr bed feelings of sadness and despair when watching presentations on global lung cancer research and medical advancements He believes that the first step to tackle the dire position of lung cancer patients in Nigeria and Africa is to understand the current standard of lung cancer care in these respective areas He calls on the global community to provide support in that regard Conclusion: Lung cancer patient experience is not only multidimensional but also diverse The key insights drawn from the interviews are that, to ensure a comprehensive lung cancer patient experience, it is crucial that: (a) lung cancer advocates are aware and mindful of social determinants as well as issues that can significantly impact on patient outcomes, including inequity, accessibility, resourcing and poverty;(b) lung cancer researchers, clinicians and policy makers actively address disparities by engaging with a wide variety of patients and caregivers in their work;and (c) the lung cancer global community is sensitive to the impact of accelerating medical advancements on the widening gap of global health inequities, and ensure that all communication is appropriately respectful The reduction of inequities is a moral obligation [4] It may be difficult to comprehend in the year of the dawn of COVID-19, but it is time for us to advance beyond just tackling diseases It is our collective ethical responsibility to consider the whole patient experience in all aspects of lung cancer care, and to do so through the lenses of health inequities As the World Health Organisation states “[r]educing health inequities is… an ethical imperative Social injustice is killing people on a grand scale ” [5] Acknowledgements: My gratitude to Caleb Egwuenu, Lily Huang and Merel Hennink for generously sharing their time and experience which significantly contributed to this presentation References: [1] Wolf, Jason A The future of patient experience: Five thoughts on where we must go from here Patient Experience Journal 2019;6(3):1 [2] Cancer Australia National Cancer Control Indicators 2019 [3] United Nations Sustainable development goals 10: Reduced inequalities [4] World Health Organisation Closing the gap in a generation: Health equity through action on the social determinants of Health WHO Press 2008 [5] Ibid, at p 40 Keywords: Health inequities, Integrated patient experience, Access to care and treatment. [4]Prostate Cancer Community
The subject matter of this work is laudable and of interest to the Asian prostate cancer community. [1] The subject matter of this work is laudable and of interest to the Asian prostate cancer community. [2] Impact: This resource is now available to the prostate cancer community as a tool for biomarker validation to address important unanswered clinical questions around disease progression and response to treatment. [3]Gynecologic Cancer Community
The international gynecologic cancer community introduced modified clinical care guidelines. [1] We look forward to working to determine the ideal surgical management of women with early stage cervical cancer and call on the gynecologic cancer community to participate. [2]nan [1] 우리는 초기 자궁경부암 여성의 이상적인 수술 관리를 결정하기 위해 노력하고 부인과 암 커뮤니티의 참여를 요청합니다. [2]
Pediatric Cancer Community
This strong collaboration and cooperation, that is the milestone of the pediatric cancer community, allowed the creation of networks fundamental for translational research discoveries and new investigators. [1] We hope that the spotlight on genomic data sharing in the United States will galvanize the world's pediatric cancer community to elevate genomic data sharing to a level where its full potential can finally be realized. [2]소아암 커뮤니티의 이정표인 이러한 강력한 협력과 협력을 통해 중개 연구 발견과 새로운 연구자를 위한 기본 네트워크를 만들 수 있었습니다. [1] 우리는 미국에서 게놈 데이터 공유에 대한 스포트라이트가 전 세계 소아암 커뮤니티에 활력을 주어 게놈 데이터 공유가 마침내 잠재력을 완전히 실현할 수 있는 수준으로 향상되기를 바랍니다. [2]
Scientific Cancer Community
IJC will continue to serve the world-wide scientific cancer community, encouraging submissions of exciting and high quality data from all over the world, and establishing itself as a leading journal with a comprehensive portfolio in cancer research. [1] This summary provides a guide to help inform the scientific cancer community about the benefits and challenges of conducting umbrella or basket trials (master trials), and to create a roadmap to help make this new and evolving form of clinical trial design as effective as possible. [2]IJC는 계속해서 전 세계 과학 암 커뮤니티에 서비스를 제공하고 전 세계의 흥미롭고 고품질 데이터 제출을 장려하고 암 연구에 대한 포괄적인 포트폴리오를 갖춘 선도적인 저널로 자리매김할 것입니다. [1] 이 요약은 과학 암 커뮤니티에 우산 또는 바구니 시험(마스터 시험) 수행의 이점과 도전에 대해 알리고 이 새롭고 진화하는 형태의 임상 시험 디자인을 가능한 한 효과적으로 만드는 데 도움이 되는 로드맵을 만드는 데 도움이 되는 가이드를 제공합니다. [2]
Childhood Cancer Community
Findings will assist the childhood cancer community in developing a comprehensive evidence-based understanding of a significant associated bio-psychosocial impact of cancer diagnosis and treatment and will form the first step towards developing effective interventions and policies to mitigate identified detrimental effects. [1] In the Philippines, the childhood cancer community has capitalized on a window of opportunity to expand access and reduce disparities in childhood cancer care through the political prioritization of UHC and NCDs in current health system reforms. [2]nan [1] 필리핀에서 소아암 커뮤니티는 현재 의료 시스템 개혁에서 UHC 및 NCD의 정치적 우선 순위를 통해 소아암 치료에 대한 접근성을 확대하고 격차를 줄일 수 있는 기회의 창을 활용했습니다. [2]
European Cancer Community
Harnessing these twin pillars of cancer research and cancer control can be transformative for the European cancer community and in particular for the European cancer patient. [1] Background: The authors are president or president-elect of Organization of European Cancer Institutes (OECI) EU Life or European Cancer Community Organization (ECCO). [2]nan [1] 배경: 저자는 유럽 암 연구소 기구(OECI) EU 생명 또는 유럽 암 커뮤니티 기구(ECCO)의 회장 또는 차기 회장입니다. [2]